Inactive Instrument
Precision Therapeutics Inc Stock Nasdaq
Stocks
US74033P1003
Biotechnology & Medical Research
| Market Cap | 40.94M 35.26M 32.45M 30.49M 57.27M 3.87B 57.93M 383M 149M 1.9B 154M 150M 6.57B | P/E Ratio 2024 |
-0.35x | P/E Ratio 2025 | -0.53x |
|---|---|---|---|---|---|
| Enterprise Value | 31.81M 27.4M 25.22M 23.69M 44.51M 3.01B 45.02M 297M 116M 1.47B 119M 117M 5.1B | EV / Sales 2024 |
4.23x | EV / Sales 2025 | 121x |
| Free-Float |
87.13% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Precision Therapeutics Inc
| 1 day | -7.56% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 09/02/2026 | |
| Director of Finance/CFO | - | 16/04/2026 | |
Kyle Okamoto
PSD | President | - | 01/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel Handley
BRD | Director/Board Member | 66 | 19/02/2020 |
Charles L. Nuzum
CHM | Chairman | 78 | 09/02/2026 |
| Director/Board Member | 60 | 09/07/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -7.56% | -8.33% | - | - | 40.49M | ||
| -0.12% | +1.04% | -13.08% | -12.43% | 43.58B | ||
| -2.17% | +5.45% | +285.76% | +522.83% | 34.03B | ||
| +0.44% | -2.46% | +14.20% | -17.35% | 29.77B | ||
| -1.60% | -2.54% | -2.12% | +31.28% | 29.82B | ||
| -0.29% | +9.47% | +13.95% | +21.93% | 25.42B | ||
| +3.54% | +12.34% | - | - | 13.87B | ||
| -1.26% | +0.81% | +54.77% | +109.24% | 13.35B | ||
| -1.04% | -3.33% | +3.98% | +3.91% | 12.85B | ||
| -1.18% | -0.61% | +105.37% | +75.32% | 12.22B | ||
| Average | -1.12% | +2.03% | +57.85% | +91.84% | 23.88B | |
| Weighted average by Cap. | -0.54% | +2.02% | +59.38% | +102.72% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.62M 1.4M 1.29M 1.21M 2.27M 154M 2.3M 15.18M 5.92M 75.19M 6.09M 5.96M 260M | 125K 108K 99.32K 93.31K 175K 11.85M 177K 1.17M 457K 5.8M 470K 460K 20.1M |
| Net income | -12.66M -10.91M -10.04M -9.43M -17.72M -1.2B -17.92M -118M -46.2M -586M -47.52M -46.52M -2.03B | -233M -201M -185M -174M -326M -22.05B -330M -2.18B -850M -10.79B -875M -856M -37.39B |
| Net Debt | 1.4M 1.2M 1.11M 1.04M 1.95M 132M 1.98M 13.06M 5.09M 64.66M 5.24M 5.13M 224M | -9.12M -7.86M -7.23M -6.8M -12.77M -863M -12.91M -85.32M -33.28M -423M -34.24M -33.51M -1.46B |
Employees
-

















